Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05391178 · ClinicalTrials.gov registry record · NA
Improving Disease Severity
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT05391178 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 18 participants.
The verdict
NCT05391178, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Phototherapy, including ultraviolet B (UVB) and ultraviolet A (UVA) light, has been used to treat a number of dermatologic conditions. Psoriasis is one of the most common conditions treated with phototherapy, in which phototherapy is often indicated for extensive disease with contraindications for other systemic treatments. The mechanism of action of phototherapy for the treatment of psoriasis is not completely understood; however, it is known that UVB light induces apoptosis of pathogenic T cells and keratinocytes, which may reduce the overactive immune response and epidermal hyperproliferation. Phototherapy has shown some efficacy for other diseases, such as alopecia areata (AA) and polymorphous light eruption (PMLE). However, phototherapy is not always an accessible treatment option for patients due to cost or lack of time.
Interventions
- OTHER Lumiton yarn sleeve
- OTHER Lumiton yarn hat
- OTHER Lumiton yarn shirt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-08-09 |
| Est. Completion | 2024-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05391178
The ClinicalTrials.gov registry entry for NCT05391178 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lumiton yarn sleeve is the first listed.
NCT05391178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05391178 about?
NCT05391178 is a clinical study titled "Improving Disease Severity". Phototherapy, including ultraviolet B (UVB) and ultraviolet A (UVA) light, has been used to treat a number of dermatologic conditions. Psoriasis is one of the most common conditions treated with phototherapy, in which phototherapy is often indicated for extensive disease with contraindications for o...
What is the current status of trial NCT05391178?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-08-09. Estimated completion is 2024-05-15.
What interventions are being tested in trial NCT05391178?
The interventions under investigation include: Lumiton yarn sleeve (OTHER), Lumiton yarn hat (OTHER), Lumiton yarn shirt (OTHER).
Who is sponsoring clinical trial NCT05391178?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.